ArticleFrontiers in neurology
Effects of ketogenic diet therapy in outpatient anti epileptic drug cost reduction and parental satisfaction among children with intractable epilepsy.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Epilepsy is a global neurological disorder that contributes to a significant disease burden in children and adolescents. About 11 million children worldwide suffer from epilepsy. Most children with epilepsy respond to anti-epileptic drugs and have controlled symptoms. However, drug-resistant epilepsy (DRE) happens in some children which presents a lot of challenges to their quality of life and development. Alternative treatment for DRE is ketogenic diet therapy (KDT) which is also given alongside the regiment. Methods: This study aims to compare the prescribed anti-epileptic drug cost of patients receiving KDT compared to the initial pre-diet cost. This study was a descriptive analytical retrospective using outpatient medical records in Dr.Cipto Mangunkusumo General Hospital (RSCM Kiara) from 2021 to 2022. Subjects were patients with drug-resistant epilepsy and underwent a ketogenic diet up to 6 months and aged between 5-18 years old. These patients were then evaluated for their anti epileptic drug costs before starting and after they did a ketogenic diet for up to 6 months with cost evaluation at 3 months interval. The cost of prescribed outpatient antiepileptic drugs were adjusted according to prices set by the Indonesian Ministry of Health. Parents of participants were also surveyed about their satisfaction with KDT using Google Form questionnaire with consent prior to survey. Results: In this study, a comparison between the overall cost of incorporating KDT for 6 months and pre-diet treatment plan was found to have a statistically significant cost reduction for the incorporation of KDT which demonstrated 21.8% overall reduction in outpatient anti epileptic drug costs among 16 patients which was found to be Rp 3,757,812 or 235 US$ ( Discussion: This study demonstrated that incorporating KDT for 6 months provides significant financial savings in treatment cost for children with drug-resistant epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.